Repair of Bone Defects With Endothelial Progenitor Cells and Bone Marrow-Derived Mesenchymal Stem Cells With...

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cell Biology

Background:

• Bone defects pose significant clinical challenges.
• Tissue engineering offers a promising solution for bone regeneration.
• Utilizing combined cell types may enhance therapeutic outcomes.

Purpose of the Study:

• To evaluate the efficacy of tissue-engineered bone for repairing bone defects.
• To investigate the role of cocultured endothelial progenitor cells (EPCs) and bone marrow mesenchymal stem cells (BMSCs) in bone repair.
• To assess the impact of cocultured cells on vascularization and osteogenesis within a scaffold.

Main Methods:

• Isolation and purification of EPCs and BMSCs from New Zealand rabbits.
• Seeding of monocultured BMSCs or cocultured EPCs and BMSCs onto a deproteinized bone scaffold.
• Implantation of engineered bone constructs to repair rabbit bone defects.
• Histological analysis (H&E, Masson staining) to evaluate vascularization and osteogenesis.

Main Results:

• Cocultured EPCs and BMSCs demonstrated robust growth on the scaffold.
• Cocultured cells significantly enhanced vascularization and osteogenesis compared to monocultured BMSCs.
• Accelerated bone defect repair and increased collagen content were observed with cocultured cells.

Conclusions:

• Tissue-engineered bone utilizing cocultured EPCs and BMSCs is effective for bone defect repair.
• The combination of EPCs and BMSCs promotes enhanced bone regeneration.
• This strategy holds potential for clinical applications in orthopedic regenerative medicine.